Pesquisando por: "Curing the" - Fotoarena - Agência de fotojornalismo

RC2WWJAQ82UI Workers carry tobacco inside a curing barn at Chaibva Farm in Marondera, Zimbabwe, March 3, 2026. The 2026 tobacco marketing season officially opens with auction sales on Wednesday. REUTERS/Philimon Bulawayo

RC2WWJA9JBXJ A woman carries tobacco inside a curing barn at Chaibva Farm in Marondera, Zimbabwe, March 3, 2026. The 2026 tobacco marketing season officially opens with auction sales on Wednesday. REUTERS/Philimon Bulawayo

RC2WWJAQWYJI A man loads tobacco inside a curing barn at Chaibva Farm in Marondera, Zimbabwe, March 3, 2026. The 2026 tobacco marketing season officially opens with auction sales on Wednesday. REUTERS/Philimon Bulawayo

RC2WWJAIV119 A woman carries tobacco inside a curing barn at Chaibva Farm in Marondera, Zimbabwe, March 3, 2026. The 2026 tobacco marketing season officially opens with auction sales on Wednesday. REUTERS/Philimon Bulawayo

RC2WWJAIEONV Workers carry tobacco inside a curing barn at Chaibva Farm in Marondera, Zimbabwe, March 3, 2026. The 2026 tobacco marketing season officially opens with auction sales on Wednesday. REUTERS/Philimon Bulawayo

RC2NZHA0LRAT A worker checks on cured tobacco for cigarettes during the commissioning of a tobacco processing plant at Cut Rag Processors (CRP) in Harare, Zimbabwe, November 19, 2025. REUTERS/Philimon Bulawayo

RC2NZHAAOIHU A worker checks on cured tobacco for cigarettes during the commissioning of a tobacco processing plant at Cut Rag Processors (CRP) in Harare, Zimbabwe, November 19, 2025. REUTERS/Philimon Bulawayo

RC2NZHAIHWDE A worker smells cured tobacco for cigarretes during the commissioning of a tobacco processing plant at Cut Rag Processors (CRP) in Harare, Zimbabwe, November 19, 2025. REUTERS/Philimon Bulawayo

RC24NFA3S4EM Kip Dove shows the remains of Smear 62, the medicine that they would carry in a special pocket in their saddles to cure cattle infected with screwworm in the 1970s in Oakville, Texas, U.S. July 15, 2025. REUTERS/Gabriel V. Cardenas

RC2Z0GA77H3Y Cure Bionics' "Hannibal" prosthetic hands are displayed on a table inside the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui CORRECTING "CURE BIONICS' PROSTHETIC HAND, "HANNIBAL," IS DISPLAYED" TO "CURE BIONICS' "HANNIBAL" PROSTHETIC HANDS ARE DISPLAYED".

RC2N2GALC4TM ATTENTION EDITORS - CAPTION CORRECTION FOR RC2Z0GA77H3Y. WE ARE SORRY FOR ANY INCONVENIENCE CAUSED. REUTERS. CORRECTING "CURE BIONICS' PROSTHETIC HAND, "HANNIBAL," IS DISPLAYED" TO "CURE BIONICS' "HANNIBAL" PROSTHETIC HANDS ARE DISPLAYED" Cure Bionics' "Hannibal" prosthetic hands are displayed on a table inside the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui TEMPLATE OUT

RC2Y0GAOIXWD Yassine Garsa, Marketing Director of Tunisian MedTech startup Cure Bionics, tests the company's bionic hand, "Hannibal", at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/ Jihed Abidellaoui

RC2Y0GA0EYBE Yassine Garsa, Marketing Director of Tunisian MedTech startup Cure Bionics, tests the company's bionic hand, "Hannibal", at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/ Jihed Abidellaoui

RC2Y0GAYLGXF Yassine Garsa, Marketing Director of Tunisian MedTech startup Cure Bionics, tests the company's bionic hand, "Hannibal," at the startup's headquarters in Sousse, Tunisia, August 5, 2025. Founded in early 2020 by Mohamed Dhaouafi, Cure Bionics develops lightweight, muscle-controlled prosthetic limbs using 3D printing and muscle-signal sensors. REUTERS/Jihed Abidellaoui

RC2Y0GAA3L7C Cure Bionics founder and CEO Mohamed Dhaouafi stands beside Marketing Director Yassine Garsa as they test the company's bionic hand, "Hannibal," at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2Y0GABBUFU Yassine Garsa, Marketing Director of Tunisian MedTech startup Cure Bionics, poses for a picture showing the company's bionic hand "Hannibal", at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2Z0GA296FR A 3D printer prints a prosthetic leg at Cure Bionics' headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2Z0GAFTE73 A Cure Bionics engineer assembles a prosthetic leg at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2Z0GAVS7BN Cure Bionics Founder and CEO Mohamed Dhaouafi stands alongside the startup's engineers as they work at their office in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2Z0GA9KB1A Cure Bionics founder and CEO Mohamed Dhaouafi poses for a picture holding the company's bionic hand, "Hannibal," at the startup's headquarters in Sousse, Tunisia, August 5, 2025. REUTERS/Jihed Abidellaoui

RC2EMFAE8AD5 An employee works inside a traditional cold room at Salumificio Santoro, as U.S. mulls 30 per cent tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo TPX IMAGES OF THE DAY

RC2FMFAV8U8L Giuseppe Santoro, owner of Salumificio Santoro, carries a rack of Capocollo di Martina Franca, traditional cured pork neck, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAJY7MI Employees work behind racks of hanging sausages in a traditional smokehouse at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFAN1F6L Giuseppe Santoro, owner of Salumificio Santoro, checks the condition of aging meats in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFAJTXT8 Cured meat products are displayed at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFA5Q3WC Cured meats hang in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFADWMDR Cured meats hang in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFAL1S34 Giuseppe Santoro, owner of Salumificio Santoro, controlls racks of Capocollo di Martina Franca, traditional cured pork neck, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFAC2YJN A cross-section of salame is inspected for quality at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAJQ1VP Giuseppe Santoro, owner of Salumificio Santoro, checks the condition of aging meats in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFA4ZUX7 Giuseppe Santoro, owner of Salumificio Santoro, checks the condition of aging meats in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFA5SUFK Employees prepare spicy salami for shipment at Salumificio Santoro, a cured meat production facility, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2FMFASCKJ6 Capocollo di Martina Franca, traditional cured pork neck being checked in a traditional cold room, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAQTDWQ Cured meats are pictured inside a basket at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAGSDX9 A worker arranges cured meats inside a cold storage facility at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAPF5U4 A fire smolders beneath racks of hanging sausages in a traditional smokehouse at Salumificio Santoro, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAWZGGU Racks of Capocollo di Martina Franca, traditional cured pork neck, hang inside a cold room at Salumificio Santoro, a cured meat production facility, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFAEMVFG An employee hangs rows of spicy salami in a maturation room at Salumificio Santoro, a cured meat production facility, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC2EMFA75RA9 Workers handle wrapped cured meats at Salumificio Santoro, a cured meat production facility, as U.S. mulls 30% tariffs on EU imports, in Cisternino, Italy, July 14, 2025. REUTERS/Alessandro Garofalo

RC25YEABUI48 A live fish is stuffed with homemade medicine before giving it to a person in belief of curing asthma and respiratory problems at a camp in Hyderabad, India, June 8, 2025. REUTERS/Almaas Masood

RC25YEAONIH9 A woman prepares to swallow a live fish stuffed with homemade medicine, in belief of curing asthma and respiratory problems at a camp in Hyderabad, India, June 8, 2025. REUTERS/Almaas Masood

RC25YEANYFRW A woman prepares to swallow a live fish stuffed with homemade medicine, in belief of curing asthma and respiratory problems at a camp in Hyderabad, India, June 8, 2025. REUTERS/Almaas Masood

RC2V1DA8WKQ5 Farmers take fresh tobacco leaves to a curing barn in San Juan y Martinez, Cuba, February 25, 2025. REUTERS/Norlys Perez

RC2XH9AX48I6 Justine Munguiko, whose child has been cured of Mpox, an infectious disease caused by the Mpox virus that causes a painful rash, enlarged lymph nodes and fever, talks with her neighbours at the Kanyaruchinya site for the internally displaced people, in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 18, 2024. REUTERS/Arlette Bashizi

RC2XH9A4VOX2 Esther Furaha, whose child is cured of Mpox, an infectious disease caused by the Mpox virus that causes a painful rash, enlarged lymph nodes and fever, cleans her laundry at the Kanyaruchinya site for the internally displaced people, in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 18, 2024. REUTERS/Arlette Bashizi

RC2XH9AAJ21V Justine Munguiko holds her child who has been cured of Mpox, an infectious disease caused by the Mpox virus that causes a painful rash, enlarged lymph nodes and fever, at the Kanyaruchinya site for the internally displaced people, in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 18, 2024. REUTERS/Arlette Bashizi

RC2XH9AD5PB7 Esther Furaha, whose child is cured of Mpox, an infectious disease caused by the Mpox virus that causes a painful rash, enlarged lymph nodes and fever, poses for a photograph at the Kanyaruchinya site for the internally displaced people, in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 18, 2024. REUTERS/Arlette Bashizi

RC2XC8A2LTO4 Cured meat products made with pork are displayed at a market stall in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8AKBS7R Dry-cured hams and pork cheeks are hung at a grocery shop in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8AYI9X0 Dry-cured hams are hung at a grocery shop in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8A3P3W7 A vendor cuts dry-cured ham at a market stall in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8ARFUWE A vendor slices dry-cured ham at a market stall in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8AJ3O11 Dry-cured hams are hung at a grocery shop in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2YC8AX003B A man walks past dry-cured hams hung outside a grocery shop in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2XC8AYTM59 A vendor sorts dry-cured hams at a grocery shop in Rome, Italy, June 17, 2024. REUTERS/Guglielmo Mangiapane

RC2Z47A1SEJW A range of Italian cure meats is displayed at the warehouse of wholesaler Tenuta Marmorelle Limited, in Thatcham, Britain, April 12, 2024. REUTERS/Isabel Infantes

RC22B6AFL6FE A farmer prepares tobacco leaves for drying at a curing barn in at a farm in San Juan y Martinez, Cuba, February 27, 2024. REUTERS/Norlys Perez

RC22B6A9205D A farmer prepares tobacco leaves for drying at a curing barn in at a farm in San Juan y Martinez, Cuba, February 27, 2024. REUTERS/Norlys Perez

RC2ID5ADBNVD A woman works inside a tobacco curing room at Little Knots farm, in Norton, Zimbabwe January 8, 2024. REUTERS/Philimon Bulawayo

RC2ID5A135Z2 A worker works inside a tobacco curing room at Little Knots farm, in Norton, Zimbabwe January 8, 2024. REUTERS/Philimon Bulawayo

RC2671AB52O8 Lydia Byron reacts while holding a tarantula during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon TPX IMAGES OF THE DAY

RC2671AUX5FH Lydia Byron holds a spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2671A11EO0 Dave, team leader, Invertebrates, holds a tarantula during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2771AW12JE Alice O’Carroll holds a tarantula during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2571AXKK21 Alice O’Carroll holds a spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2771AG2EH1 A zookeeper holds a tarantula during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2671AJMYII Laura Corbett holds a Tarantula during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2671A00C9K Gemma Ogundele photographs a spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2471A65I2O A participant looks at spiders during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2571AB1IYF Gemma Ogundele gets emotional walking under spiders during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2571AFY2AO Laura Corbett traps a spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2571AJG5R2 Alice O’Carroll holds a spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2471AKN6M1 Participants walk past spiders during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC2771AY22U7 Savannah Corbett, aged 8, holds a house spider during London Zoo's Friendly Spider Programme , a course that aims to cure attendees of arachnophobia in London, Britain May 27, 2023. REUTERS/Anna Gordon

RC27MZ9QCYBZ Farm workers grading cured tobacco at Tzoro farm in Centenary, Zimbabwe, March 3, 2023 REUTERS/Philimon Bulawayo

RC28MZ9SXTGR Farm worker Kingstone Phiri, 64, grading cured tobacco with other farm workers at Tzoro farm in Centenary, Zimbabwe, March 3, 2023 REUTERS/Philimon Bulawayo

RC28MZ9JVKGE Women pack cured tobacco at Tzoro farm in Centenary, Zimbabwe, March 3, 2023 REUTERS/Philimon Bulawayo

RC28MZ94J2GN Farm workers grading cured tobacco at Tzoro farm in Centenary, Zimbabwe, March 3, 2023 REUTERS/Philimon Bulawayo

RC23JX9QJSHT Steam rises off of piles of compost as it cures before the final step of compost processing at Recology Blossom Valley Organics North near Vernalis, California, U.S., November 10, 2022. REUTERS/Brittany Hosea-Small

RC23JX980LIR Steam rises off of piles of compost as it cures before the final step of compost processing at Recology Blossom Valley Organics North near Vernalis, California, U.S., November 10, 2022. REUTERS/Brittany Hosea-Small

RC23JX9OD0HP Steam rises off of piles of compost as it cures before the final step of compost processing at Recology Blossom Valley Organics North near Vernalis, California, U.S., November 10, 2022. REUTERS/Brittany Hosea-Small

RC23JX9V6N3D Steam rises off of piles of compost as it cures before the final step of compost processing at Recology Blossom Valley Organics North near Vernalis, California, U.S., November 10, 2022. REUTERS/Brittany Hosea-Small

RC28LX96QJYY Staff work to 'cure' ballots, the process of contacting the voter to allow them to amend or correct issues with their ballot, for the U.S. midterm elections at the Maricopa County Tabulation and Election Center in Phoenix, Arizona, U.S., November 13, 2022. REUTERS/Jim Urquhart

RC28LX9FKUC9 Staff work to 'cure' ballots, the process of contacting the voter to allow them to amend or correct issues with their ballot, for the U.S. midterm elections at the Maricopa County Tabulation and Election Center in Phoenix, Arizona, U.S., November 13, 2022. REUTERS/Jim Urquhart

RC2Y9V942A53 Hunter Cure of Holliday, Texas wrestles a steer in the steer wrestling event during the Calgary Stampede rodeo in Calgary, Alberta, Canada July 11, 2022. REUTERS/Todd Korol

RC213V9U1NUH Founding CEO of AiCuris Antiinfective Cures Helga Rubsamen-Schaeff hands German Health Minister Karl Lauterbach an evaluation report of experts advising the German government about the measures to fight the coronavirus pandemic (COVID-19), in Berlin, Germany, July 1, 2022. REUTERS/Lisi Niesner

RC213V9CCKMM Founding CEO of AiCuris Antiinfective Cures Helga Rubsamen-Schaeff shakes hands with German Health Minister Karl Lauterbach, as he receives an evaluation report of experts advising the German government about the measures to fight the coronavirus pandemic (COVID-19), in Berlin, Germany, July 1, 2022. REUTERS/Lisi Niesner

RC213V9BF1TD Founding CEO of AiCuris Antiinfective Cures Helga Rubsamen-Schaeff shakes hands with German Health Minister Karl Lauterbach, as he receives an evaluation report of experts advising the German government about the measures to fight the coronavirus pandemic (COVID-19), in Berlin, Germany, July 1, 2022. REUTERS/Lisi Niesner

RC255T9VZ8WR U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9X2RUL U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9IGX3E U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9DNBY3 U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9YJKV1 U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9IT48P U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9IC4NJ U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9FBKD3 U.S. President Joe Biden speaks during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9EB4WC U.S. President Joe Biden looks over his notes during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC255T9C9LL7 Dr. Lisa Cooper, member of the President's Council of Advisors on Science and Technology (PCAST), waits prior to a meeting with U.S. President Joe Biden, not pictured, about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC245T9UW0VX Dr. Eric Lander, director of the Office of Science and Technology Policy (OSTP), arrives for a meeting with U.S. President Joe Biden, not pictured, about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago

RC245T9OKSUV U.S. President Joe Biden arrives during a meeting about ARPA-H, a health research agency that seeks to accelerate progress on curing cancer and additional health innovations, in the South Court Auditorium on the White House complex, in Washington, U.S., March 18, 2022. REUTERS/Al Drago